Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.

Reuter CW, Krauter J, Onono FO, Bunke T, Damm F, Thol F, Wagner K, Göhring G, Schlegelberger B, Heuser M, Ganser A, Morgan MA.

Ann Hematol. 2014 Jun;93(6):977-82. doi: 10.1007/s00277-014-2061-9. Epub 2014 Apr 16.

PMID:
24737308
[PubMed - indexed for MEDLINE]
2.

Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.

Cagnetta A, Adamia S, Acharya C, Patrone F, Miglino M, Nencioni A, Gobbi M, Cea M.

Leuk Res. 2014 Jun;38(6):649-59. doi: 10.1016/j.leukres.2014.03.006. Epub 2014 Mar 18. Review.

PMID:
24726781
[PubMed - indexed for MEDLINE]
3.

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.

Pastore F, Dufour A, Benthaus T, Metzeler KH, Maharry KS, Schneider S, Ksienzyk B, Mellert G, Zellmeier E, Kakadia PM, Unterhalt M, Feuring-Buske M, Buske C, Braess J, Sauerland MC, Heinecke A, Krug U, Berdel WE, Buechner T, Woermann B, Hiddemann W, Bohlander SK, Marcucci G, Spiekermann K, Bloomfield CD, Hoster E.

J Clin Oncol. 2014 May 20;32(15):1586-94. doi: 10.1200/JCO.2013.52.3480. Epub 2014 Apr 7.

PMID:
24711548
[PubMed - indexed for MEDLINE]
4.

MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.

Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI.

Leuk Res. 2014 May;38(5):625-31. doi: 10.1016/j.leukres.2014.03.008. Epub 2014 Mar 19.

PMID:
24703161
[PubMed - indexed for MEDLINE]
5.

Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

West AH, Godley LA, Churpek JE.

Ann N Y Acad Sci. 2014 Mar;1310:111-8. doi: 10.1111/nyas.12346. Epub 2014 Jan 27. Review.

PMID:
24467820
[PubMed - indexed for MEDLINE]
6.

Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.

Iriyama N, Asou N, Miyazaki Y, Yamaguchi S, Sato S, Sakura T, Maeda T, Handa H, Takahashi M, Ohtake S, Hatta Y, Sakamaki H, Honda S, Taki T, Taniwaki M, Miyawaki S, Ohnishi K, Kobayashi Y, Naoe T.

Ann Hematol. 2014 Jun;93(6):957-63. doi: 10.1007/s00277-014-2013-4. Epub 2014 Jan 19.

PMID:
24441947
[PubMed - indexed for MEDLINE]
7.

Initiation of MLL-rearranged AML is dependent on C/EBPα.

Ohlsson E, Hasemann MS, Willer A, Lauridsen FK, Rapin N, Jendholm J, Porse BT.

J Exp Med. 2014 Jan 13;211(1):5-13. doi: 10.1084/jem.20130932. Epub 2013 Dec 23.

PMID:
24367003
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Sox4you: a new player in C/EBPα leukemia.

Fung TK, Leung AY, So CW.

Cancer Cell. 2013 Nov 11;24(5):557-9. doi: 10.1016/j.ccr.2013.10.016.

PMID:
24229703
[PubMed - indexed for MEDLINE]
9.

Associations between age, cytogenetics, FLT3-ITD, and marrow leukemia cells identified by flow cytometry.

Su L, Gao SJ, Tan YH, Han W, Li W.

Asian Pac J Cancer Prev. 2013;14(9):5341-4.

PMID:
24175822
[PubMed - indexed for MEDLINE]
Free Article
10.

MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia.

Díaz-Beyá M, Brunet S, Nomdedéu J, Tejero R, Díaz T, Pratcorona M, Tormo M, Ribera JM, Escoda L, Duarte R, Gallardo D, Heras I, Queipo de Llano MP, Bargay J, Monzo M, Sierra J, Navarro A, Esteve J; Cooperative AML group CETLAM (Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias).

Leukemia. 2014 Apr;28(4):804-12. doi: 10.1038/leu.2013.281. Epub 2013 Sep 27.

PMID:
24072101
[PubMed - indexed for MEDLINE]
11.

The role of different genetic subtypes of CEBPA mutated AML.

Fasan A, Haferlach C, Alpermann T, Jeromin S, Grossmann V, Eder C, Weissmann S, Dicker F, Kohlmann A, Schindela S, Kern W, Haferlach T, Schnittger S.

Leukemia. 2014 Apr;28(4):794-803. doi: 10.1038/leu.2013.273. Epub 2013 Sep 23.

PMID:
24056881
[PubMed - indexed for MEDLINE]
12.

CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic risk.

Park SH, Chi HS, Cho YU, Jang S, Park CJ.

Leuk Res. 2013 Nov;37(11):1488-94. doi: 10.1016/j.leukres.2013.08.014. Epub 2013 Sep 5.

PMID:
24054719
[PubMed - indexed for MEDLINE]
13.

NUP98-NSD1 fusion in association with FLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR.

Akiki S, Dyer SA, Grimwade D, Ivey A, Abou-Zeid N, Borrow J, Jeffries S, Caddick J, Newell H, Begum S, Tawana K, Mason J, Velangi M, Griffiths M.

Genes Chromosomes Cancer. 2013 Nov;52(11):1053-64. doi: 10.1002/gcc.22100. Epub 2013 Sep 2.

PMID:
23999921
[PubMed - indexed for MEDLINE]
14.

Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.

Katzerke C, Madan V, Gerloff D, Bräuer-Hartmann D, Hartmann JU, Wurm AA, Müller-Tidow C, Schnittger S, Tenen DG, Niederwieser D, Behre G.

Blood. 2013 Oct 3;122(14):2433-42. doi: 10.1182/blood-2012-12-472183. Epub 2013 Aug 23.

PMID:
23974200
[PubMed - indexed for MEDLINE]
15.

Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia.

Yang WC, Tsai WC, Lin PM, Yang MY, Liu YC, Chang CS, Yu WH, Lin SF.

J Biomed Sci. 2013 Aug 14;20:58. doi: 10.1186/1423-0127-20-58.

PMID:
23941109
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.

Hou HA, Lin CC, Chou WC, Liu CY, Chen CY, Tang JL, Lai YJ, Tseng MH, Huang CF, Chiang YC, Lee FY, Kuo YY, Lee MC, Liu MC, Liu CW, Lin LI, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

Leukemia. 2014 Jan;28(1):50-8. doi: 10.1038/leu.2013.236. Epub 2013 Aug 9.

PMID:
23929217
[PubMed - indexed for MEDLINE]
17.

The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA.

Schlenk RF, Taskesen E, van Norden Y, Krauter J, Ganser A, Bullinger L, Gaidzik VI, Paschka P, Corbacioglu A, Göhring G, Kündgen A, Held G, Götze K, Vellenga E, Kuball J, Schanz U, Passweg J, Pabst T, Maertens J, Ossenkoppele GJ, Delwel R, Döhner H, Cornelissen JJ, Döhner K, Löwenberg B.

Blood. 2013 Aug 29;122(9):1576-82. doi: 10.1182/blood-2013-05-503847. Epub 2013 Jul 17.

PMID:
23863898
[PubMed - indexed for MEDLINE]
18.

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.

Metzeler KH, Maharry K, Kohlschmidt J, Volinia S, Mrózek K, Becker H, Nicolet D, Whitman SP, Mendler JH, Schwind S, Eisfeld AK, Wu YZ, Powell BL, Carter TH, Wetzler M, Kolitz JE, Baer MR, Carroll AJ, Stone RM, Caligiuri MA, Marcucci G, Bloomfield CD.

Leukemia. 2013 Oct;27(10):2023-31. doi: 10.1038/leu.2013.181. Epub 2013 Jun 14.

PMID:
23765227
[PubMed - indexed for MEDLINE]
19.

Pediatric acute myeloid leukemia as classified using 2008 WHO criteria: a single-center experience.

Davis KL, Marina N, Arber DA, Ma L, Cherry A, Dahl GV, Heerema-McKenney A.

Am J Clin Pathol. 2013 Jun;139(6):818-25. doi: 10.1309/AJCP59WKRZVNHETN.

PMID:
23690127
[PubMed - indexed for MEDLINE]
Free Article
20.

Molecular genetic tests for FLT3, NPM1, and CEBPA in acute myeloid leukemia.

Zhang Q, Bai S, Vance GH.

Methods Mol Biol. 2013;999:105-21. doi: 10.1007/978-1-62703-357-2_7.

PMID:
23666693
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk